Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Allogeneic Stem Cell Transplantation Using In Vivo T-Cell Depletion in Myeloid Disorders

Muhammad Ameer Saif, MDFRCPath,MBBS,MRCP, Maryem Zine, Andrew Turner, Helena Lee, PhD, Fiona L Dignan, MRCP FRCPath MD(Res), Eleni Tholouli

Blood (2015) 126 (23): 5451.

https://doi.org/10.1182/blood.V126.23.5451.5451

Published: 2015

Journal Articles

High Readmission Costs in Patients with Respiratory Syncytial Virus Following Haematopoietic Stem Cell Transplantation

Claudia M Gorcea, Eleni Tholouli, Andrew Turner, Fiona L Dignan

Blood (2014) 124 (21): 6019.

https://doi.org/10.1182/blood.V124.21.6019.6019

Published: 2014

Journal Articles

A Multicentre Retrospective UK Study Detailing Onset Of Graft Verus Host Disease, Responses To Treatment and Outcome After Donor Lymphocyte Infusion Following Haemopoietic Stem Cell Transpantation: Rates Of GVHD Are High But Death From GVHD Infrequent

Julia J Scarisbrick, MBhons ChB FRCP MD, Fiona L Dignan, Sameer Tulpule, Emma Das gupta, Gulnaz Shah, Antonio Pagliuca, Ram Malladi, Kavita Raj, MD, PhD, MRCP, FRCPath

Blood (2013) 122 (21): 4645.

https://doi.org/10.1182/blood.V122.21.4645.4645

Published: 2013

Journal Articles

High Readmission Rates Are Associated with a Significant Economic Burden and Poor Outcome in Patients with Grade 3/4 Acute GvHD

Fiona L Dignan, Michael N Potter, Mark E Ethell, Joy Brennan, Louise McNamara, Stephen O Evans, Claire E. Dearden, Faith E Davies, MD, Gareth J Morgan, MD PhD, Bronwen E. Shaw

Blood (2011) 118 (21): 2061.

https://doi.org/10.1182/blood.V118.21.2061.2061

Published: 2011

Journal Articles

Reduced Intensity Allogeneic Tranplants Are Well Tolerated In Patients Over the Age of 60: Identification of Factors Predicting Overall Survival

Emmanouil Nikolousis, Sandeep Nagra, Janice Ward, Fiona L Dignan, MD, Bronwen E. Shaw, PhD, MRCP, FRCPath, Simon Littlewood, Jenny Byrne, MD, PhD, Maria Helena Gilleece, MD, FRCPath, MB, BSc, FRCP, Eleni Tholouli, Fiona Clark, Mark Cook, Premini Mahendra, MD, Gordon Cook, MD, John Yin, MD, Nigel H. Russell, MD, Charles Craddock

Blood (2010) 116 (21): 2361.

https://doi.org/10.1182/blood.V116.21.2361.2361

Published: 2010

Journal Articles

Positive Effect of Extracorporeal Photopheresis In Reducing Immunosuppression in Patients with Chronic Graft Versus Host Disease.

Fiona L Dignan, BSc, MRCP, FRCPath, Danielle Greenblatt, MRCP, Michael Cox, Bronwen E. Shaw, PhD, MRCP, FRCPath, Julia J Scarisbrick, MD, MRCP

Blood (2010) 116 (21): 3452.

https://doi.org/10.1182/blood.V116.21.3452.3452

Published: 2010

Journal Articles

The Presence of Minimal Residual Disease Pre- and Post-Transplant Is Predictive of Outcome in Recipients of Allogeneic Transplantation for Acute Myeloid Leukaemia.

Fiona L Dignan, Chloe Anthias, Mark E Ethell, Ricardo Morilla, Alison Morilla, Faith E Davies, MD, Gareth J Morgan, Michael N Potter, Bronwen E Shaw

Blood (2009) 114 (22): 2601.

https://doi.org/10.1182/blood.V114.22.2601.2601

Published: 2009

Journal Articles

An Early CT-Diagnosis Based Treatment Strategy for Invasive Fungal Infection in Allogeneic Transplant Recipients Using Caspofungin First Line: An Effective Strategy with Low Mortality.

Fiona L Dignan, Stephen O Evans, Mark E Ethell, Bronwen E. Shaw, Unell BG Riley, Faith Davies, Jennifer G. Treleaven, Claire E. Dearden, Gareth J. Morgan, Michael N Potter

Blood (2008) 112 (11): 1149.

https://doi.org/10.1182/blood.V112.11.1149.1149

Published: 2008

Journal Articles

Prophylactic Defibrotide in Allogeneic Stem Cell Transplantation: Low Morbidity and Zero Mortality from Veno-Occlusive Disease.

Fiona L. Dignan, BSc, MRCP, Dorothy Gujral, MRCP, Mark E. Ethell, MD MRCP MRCPath, Jennifer Treleaven, FRCP FRCPath, Gareth Morgan, PhD FRCP FRCPath, Michael Potter, PhD FRCP FRCPath

Blood (2006) 108 (11): 2968.

https://doi.org/10.1182/blood.V108.11.2968.2968

Published: 2006

Journal Articles

Parainfluenza Virus Type 3 Post Stem Cell Transplant: High Prevalence but Low Mortality.

Fiona L. Dignan, BSc, MRCP, Caroline L. Alvares, BSc, MRCP, MRCPath, Unell Riley, MRCP, Mark E. Ethell, MD, MRCP, MRCPath, David C. Cunningham, MD, FRCP, Jennifer Treleavan, MD, FRCP, FRCPath, Michael Potter, PhD, FRCP, FRCPath

Blood (2005) 106 (11): 3229.

https://doi.org/10.1182/blood.V106.11.3229.3229

Published: 2005

NARROW

Allogeneic Stem Cell Transplantation Using In Vivo T-Cell Depletion in Myeloid Disorders

High Readmission Costs in Patients with Respiratory Syncytial Virus Following Haematopoietic Stem Cell Transplantation

A Multicentre Retrospective UK Study Detailing Onset Of Graft Verus Host Disease, Responses To Treatment and Outcome After Donor Lymphocyte Infusion Following Haemopoietic Stem Cell Transpantation: Rates Of GVHD Are High But Death From GVHD Infrequent

High Readmission Rates Are Associated with a Significant Economic Burden and Poor Outcome in Patients with Grade 3/4 Acute GvHD

Reduced Intensity Allogeneic Tranplants Are Well Tolerated In Patients Over the Age of 60: Identification of Factors Predicting Overall Survival

Positive Effect of Extracorporeal Photopheresis In Reducing Immunosuppression in Patients with Chronic Graft Versus Host Disease.

The Presence of Minimal Residual Disease Pre- and Post-Transplant Is Predictive of Outcome in Recipients of Allogeneic Transplantation for Acute Myeloid Leukaemia.

An Early CT-Diagnosis Based Treatment Strategy for Invasive Fungal Infection in Allogeneic Transplant Recipients Using Caspofungin First Line: An Effective Strategy with Low Mortality.

Prophylactic Defibrotide in Allogeneic Stem Cell Transplantation: Low Morbidity and Zero Mortality from Veno-Occlusive Disease.

Parainfluenza Virus Type 3 Post Stem Cell Transplant: High Prevalence but Low Mortality.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only